FindTrial
Sign In

Clinical outcomes of hospitalized COVID-19 Omicron patients treated with TCM Therapy: a real-word retrospective analysis of a large Medical Center in Shanghai China

Clinical outcomes of hospitalized COVID-19 Omicron patients treated with TCM Therapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200006655
Enrollment
Unknown
Registered
2022-09-26
Start date
2022-09-12
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV-2 Omicron

Interventions

West Medicine Group:Nil
chinese herb medicine group:Nil

Sponsors

Shanghai Pudong Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 102 Years

Inclusion criteria

Inclusion criteria: (1) ARS-CoV-2 Omicron infection conformed by polymerase chain reaction (PCR) test; (2) Diagnosed between April 6- June 30, 2022; (3) Adults over 18 years old; (4) Inpatients with COVID-19 in our hospital.(5)Hospitalization days less than 28 days

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Hospitalization days;the negative conversion time ;—

Countries

china

Contacts

Public ContactZeng Yipeng
zengyipengdoc@126.com13661957967

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026